Article info

Download PDFPDF
Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer

Authors

  • W. A. Verborg Division of Cancer Medicine, Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom PubMed articlesGoogle scholar articles
  • L. R. Campbell Division of Cancer Medicine, Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom PubMed articlesGoogle scholar articles
  • M. S. Highley Division of Cancer Medicine, Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom PubMed articlesGoogle scholar articles
  • E. M. Rankin Division of Cancer Medicine, Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to: Elaine M. Rankin, MD, FRCP, Division of Cancer Medicine, Biomedical Research Centre, Level 5, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. Email: e.m.rankin{at}dundee.ac.uk

Citation

Verborg WA, Campbell LR, Highley MS, et al
Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer

Publication history

  • First published February 1, 2008.
Online issue publication 
March 06, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.